Piperazine → HCID 13371675, compound

HRID 638176Notes

Reaction equation

[CH2:1]([NH:8][C:9]1[N:18]=[C:17]2[C:12]([C:13]([N:20]3[CH2:25][CH2:24][S:23](=[O:26])[CH2:22][CH2:21]3)=[N:14][C:15](Cl)=[N:16]2)=[N:11][C:10]=1[Cl:27])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[NH:28]1[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]1>>[CH2:1]([NH:8][C:9]1[N:18]=[C:17]2[C:12]([C:13]([N:20]3[CH2:25][CH2:24][S:23](=[O:26])[CH2:22][CH2:21]3)=[N:14][C:15]([N:28]3[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]3)=[N:16]2)=[N:11][C:10]=1[Cl:27])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1

Participants

Reactant 2

HCID 4837Piperazine

HCID 13371664HCID 13371664, compound

Product 1

HCID 13371675HCID 13371675, compound

Procedure

This compound was prepared analogous to Example 1 from 7-benzylamino-2,6-dichloro-4-(1-oxido-thiomorpholino)pteridine and piperazine.

Sources & evidence

ORD record: ord-35369d16fd6d40c4b4d2f2c6dba2af25
Source dataset: uspto-grants-1985_12
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US04560685

Reaction notes

Loading…